Benchmark fetal bovine serum - 68 units of lot # A423008

Closed Pre-Solicitation Posted

Solicitation number
NOI-NIAID-23-2187095
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6509 Drugs And Biologicals, Veterinary Use
Place of performance
Bethesda, Maryland 20814, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases (NIAID) intends to negotiate a contract with Gemini Bio Products Inc. for the procurement of 68 units of Benchmark Fetal Bovine Serum (FBS), including all shipping, handling, and dry ice charges to the NIH Clinical Center. The FBS will be used in the Integrative Immunobiology Section's research on gene expression in early B cell development. The contract is not open to competition due to the specific requirements of the project, but capability statements from other potential providers will be considered until August 31, 2023.

Products and Services:

  1. Benchmark Fetal Bovine Serum (FBS) - 68 units of Lot number A423008.
  2. Shipping to NIH Clinical Center.
  3. Handling charges.
  4. Dry ice charges.
  5. Continuity and integrity of data results.

Notice text

This is a Notice of Intent, not a request for proposal.  The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Gemini Bio Products Inc., to procure:  

1)    Benchmark Fetal Bovine Serum (FBS), 68 units of Lot number A423008, CAT # 100-106-500  (500ML/ BOTTLE) 
2)    To include:  Shipping to NIH. Clinical Center, 10 Center Drive, Bethesda, MD  20814 FOB Destination, include all shipping, handling and dry ice charges.   

The Integrative Immunobiology Section of Laboratory of Immune System Biology is interested in how gene expression is orchestrated as cell differentiate from stem cells into effector cells in the immune system. In particular, the laboratory will study how these systems are controlled by gene expression in determining early B cell development. 
 
The FBS provided by GeminiBio has proved to be the best option for optimal results in all of our experiments and cell culture for this project. Therefore, FBS from GeminiBio is the only source we can use for our very critical experiments. Gemini Bioproducts has the specific Lot # A423008 and no other Lot # is acceptable. This serum will be used over the term of the project for continuity and the integrity of our data results.  

The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.  All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-23-2187095 to Diana Rohlman at by 4:00 pm eastern standard time August 31, 2023.  All responses received by the closing date of this synopsis will be considered by the Government.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.


 

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors